Drugs, dreams, and nightmares

Sleep Medicine Clinics

Volumn 5, Issue 2, 2010, Pages 277-287

  Pagel, J F ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b Sleep Disorders Center of Southern Colorado   (United States)

^c Sleepworks Sleep Laboratory   (United States)

Author keywords

Dream; Medications; Nightmares; Parasomnias; PTSD

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATENOLOL; BENZODIAZEPIN 2 ONE DERIVATIVE; BISOPROLOL; BROMOCRIPTINE; CHLORPHENIRAMINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; FLEROXACIN; FLUVOXAMINE; HYPNOTIC AGENT; MINOXIDIL; MOOD STABILIZER; NEFAZODONE; NEUROLEPTIC AGENT; NICOTINE; PERGOLIDE; PRAMIPEXOLE; PRAZOSIN; PROPRANOLOL; RIVASTIGMINE; TRAZODONE; TRIAZOLAM; UNINDEXED DRUG; VARENICLINE;

ABNORMAL DREAMING; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; CONFUSION; DREAMING; HALLUCINATION; HUMAN; INSOMNIA; NEUROCHEMISTRY; NEUROMODULATION; NEUROTOXICITY; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REM SLEEP; REVIEW;

EID: 77956628840     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2010.01.007     Document Type: Review

References (65)

1. D. Foulkes Dreaming: a cognitive-psychological analysis 1985 Lawrence Erlbaum Associates Hillsdale (NJ)
2. M. Solms The neurophysiology of dreams: a clinico-anatomical study 1997 Lawrence Erlbaum Mahwah (NJ)
3. J.F. Pagel The limits of dream - a scientific exploration of the mind/brain interface 2008 Academic Press (Elsiever) Oxford (UK)
4. G.W. Domhoff The scientific study of dreams - neural networks, cognitive development, and content analysis 2003 American Psychological Association Washington, DC
5. J.F. Pagel, and P. Helfer Drug induced nightmares - an etiology based review Hum Psychopharmacol 18 2003 59 67
6. J.F. Pagel The neuropharmacology of nightmares in "sleep and sleep disorders: neuropsychopharmacologic approach" S.R. Pandi-Perumal, D.P. Cardinali, M. Lander, Sleep and sleep disorders: a neuropsychopharmacologic approach 2006 Landes Bioscience Georgetown (TX) 225 240
7. E.R. Kandle The brain and behavior E.R. Kandel, J.H. Schwartz, T.M. Jessell, Principles of neural science 4th edition 2000 McGraw Hill New York 5 18
8. J.H. Schwartz Neurotransmitters E.R. Kandel, J.H. Schwartz, T.M. Jessell, Principles of neural science 4th edition 2000 McGraw Hill New York 280 297
9. R. McCarley, and J. Hobson Neuronal excitability modulation over the sleep cycle: a structural and mathematical model Science 189 1975 58 60
10. J. Hobson, E. Pace-Schott, and R. Stickgold E. Pace-Schott, M. Solms, M. Blagtove, Dreaming and the brain: toward a cognitive neuroscience of conscious states in sleep and dreaming: scientific advances and reconsiderations 2003 1 50
11. E.F. Pace-Schott Postscript: recent findings on the neurobiology of sleep and dreaming E.F. Pace-Schott, M. Solms, M. Blagrove, Sleep and dreaming: scientific advances and reconsiderations 2003 Cambridge University Press Cambridge (UK) 335 350
12. A.J. Bundley, J.R. Hughes, and B.A. Moore Marijuana abstinence effects in marijuana smokers maintained in their home environment Arch Gen Psychiatry 58 10 2001 917 924
13. D.T. Wade, P.M. Makela, and H. House Long term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis Mult Scler 12 5 2006 639 645
14. J.A. Hobson, and M. Steriade The neuronal basis of behavioral state control: internal regulatory systems of the brain F. Bloom, V. Mountcastle, Handbook of psychology vol. IV 1986 American Physiological Society Washington, DC 701 823 (14)
15. M. Steriade Brain electrical activity and sensory processing during waking and sleeping states M.H. Kryger, T. Roth, W.C. Dement, Principles and practice of sleep medicine 3rd edition 2000 W.B. Saunders Co Philadelphia 93 111
16. E. Perry, and R. Perry Acetylcholine and hallucinations: disease related compared to drug induced alterations in human consciousness Brain Cogn 28 1995 240 258
17. D. Thompson, and D. Pierce Drug induced nightmares Ann Pharmacother 33 1999 93 96
18. J. Dimsdale, and R. Newton Cognitive effects of beta-blockers J Psychosom Res 36 3 1991 229 236
19. K. Brismar, L. Motgensen, and L. Wetterberg Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs Acta Med Scand 221 2 1987 155 158
20. N.J. Coupland, C.J. Bell, and J.P. Potokar Serotonin reuptake inhibitor withdrawal J Clin Psychopharmacol 16 5 1996 356 362
21. E. Pace-Schott, T. Gersh, and R. Silvestri Effects of serotonin reuptake inhibitors (SSRI) on dreaming in normal subjects Sleep 22 Suppl 1 1999 H278D
22. E. Lepkifker, P.N. Dannon, and I. Iancu Nightmares related to fluoxetine treatment Clin Neuropharmacol 18 1 1995 90 94
23. E. Pace-Schott, T. Gersh, and R. Silvestri Enhancement of subjective intensity of dream features in normal subjects by the SSRI's paroxetine and fluvoxamine Sleep 23 Suppl 2 2000 A173
24. M. Stacy Managing late complications of Parkinson's disease Med Clin North Am 83 2 1999 469 481
25. J. Atack Anxioselective compounds acting at the GABA A receptor benzodiazepine binding site Curr Drug Targets CNS Neurol Disord 2 2003 213 232
26. P. Whiting GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 8 2003 445 450
27. K. Wafford, R. Macaulay, and G. O'Meara Differentiating the role of γ - aminobutyric acid type A (GABA A) receptor subtypes Biochem Soc Trans 32 2004 553 556
28. P. Krogsgaard-Larsen, B. Frolund, and T. Liljefors Specific GABA A agonists and partial agonists Chem Rec 2 2002 419 430
29. S. Stahl Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes J Clin Psychiatry 63 2002 179 180
30. S. Rassnick, J. Krechman, and G. Koob Chronic ethanol produces a decreased sensitivity to the response - disruptive effects of GABA receptor complex antagonists Pharmacol Biochem Behav 44 1993 943 950
31. R. Schlosser, T. Gesierich, and G. Wagner Altered benzodiazepine receptor sensitivity in alcoholism: a study with fMRI and acute lorazepam challenge Psychiatry Res 154 2007 241 251
32. S. Collis, D. Wade, and J. Londen Neurochemical alterations produced by daily nicotine exposure in peri-adolescent versus adult rats Eur J Pharmacol 502 2004 75 85
33. E. Ciani, S. Severi, and R. Bartesaghi Neurochemical correlates of nicotine neurotoxicity on rat habenulo-interpedicular cholinergic neurons Neurotoxicology 26 3 2005 467 474
34. T.M. Smith, and F.D. Winters Smoking cessation: a clinical study of the trans dermal nicotine patch J Am Osteopath Assoc 95 11 1995 655 656 661-2
35. R.G. Ivers, M. Farrington, and C.B. Burns A study of the use of free nicotine patches by indigenous people Aust N Z J Public Health 27 5 2003 486 490
36. S. Lam, and P.N. Patel Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation Cardiol Rev 15 3 2007 154 161
37. J.M. Krueger, and J. Fang Host defense M. Kryger, T. Roth, W. Dement, Principles and practice of sleep medicine vol. 3 2000 W.B. Saunders Co Philadelphia 255 265
38. J.M. Krueger, S. Kubillis, and S. Shoham Enhancement of slow wave sleep by endotoxin and libid A Am J Phys 251 1986 R591 R597
39. S.E. Jaffe Sleep and infectious disease M. Kryger, T. Roth, W. Dement, Principles and Practice of sleep medicine vol. 3 2000 W.B. Saunders Co Philadelphia 1093 1102
40. S. Marsh, H.G. Schaefer, and C. Tschau Dreaming and anesthesia: total i.v. anaesthesia with propofol versus balanced volitile anaeshthesia with enflurane Eur J Anaesthesiol 9 1992 331 333
41. J. Krissel, W.F. Dick, and K.H. Leysen Thiopentone, thiopentone/ketamine, and ketamine for induction of anesthesia in caesarean section Eur J Anaesthesiol 11 1994 115 122
42. D. Oxorn, L.E. Ferris, and E. Harrington The effects of midazolam on propofol-induced anesthesia: propofol dose requirements, mood profiles, and perioperative dreams Anesth Analg 85 1997 553 559
43. J.A. Hobson Dreaming as delerium 1999 MIT Press Cambridge Mass
44. C. Guilleminault, L. Palombini, and R. Pelayo Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics 111 1 2003 e17 e25
45. C.H. Schenck, T.D. Hurwitz, and M.W. Mahowald Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature J Sleep Res 2 4 1993 224 231
46. C.H. Schenck, Mahowald, and M.W. Parasomnias Managing bizarre sleep-related behavior disorders Postgrad Med 107 3 2000 145 156
47. B. Krakow, R. Kellner, and D. Pathak Imagery rehearsal treatment for chronic nightmares Behav Res Ther 33 7 1995 837 843
48. M. Robertson, L. Humphreys, and R. Ray Psychological treatments for posttraumatic stress disorder: recommendations for the clinician based on a review of the literature J Psychiatr Pract 10 2 2004 106 118
49. B. Krakow, and J. Niedhardt Conquering bad dreams and nightmares 1992 Berkley Books New York
50. M. Burgess, M. Gill, and I. Marks Postal self-exposure treatment of recurrent nightmares. Randomised controlled trial Br J Psychiatry 172 1998 257 262
51. J. Bisson, and M. Andrew Psychological treatment of post-traumatic stress disorder (PTSD) Cochrane Database Syst Rev 2 2005 CD003388
52. F.W. Putnam, and J.E. Hulsmann Pharmacotherapy for survivors of childhood trauma Semin Clin Neuropsychiatry 7 2 2002 129 136
53. F.B. Schoenfeld, C.R. Marmar, and T.C. Neylan Current concepts in pharmacotherapy for posttraumatic stress disorder Psychiatr Serv 55 5 2004 519 531
54. M.H. Rapaport, J. Endicott, and C.M. Clary Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment J Clin Psychiatry 63 1 2002 59 65
55. G. Bartzokis, P.H. Lu, and J. Turner Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder Biol Psychiatry 57 5 2005 474 479
56. J. Douglas Bremner, T. Mletzko, and S. Welter Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study J Clin Psychiatry 65 11 2004 1559 1564
57. M.B. Hamner, P.S. Brodrick, and L.A. Labbate Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy Ann Clin Psychiatry 13 3 2001 141 146
58. M. Wheatley, J. Plant, and H. Reader Clozapine treatment of adolescents with posttraumatic stress disorder and psychotic symptoms J Clin Psychopharmacol 24 2 2004 167 173
59. J.R. Davidson, R.H. Weisler, and M.I. Butterfield Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial Biol Psychiatry 53 2 2003 188 191
60. T.A. Mellman, V. Bustamante, and D. David Hypnotic medication in the aftermath of trauma J Clin Psychiatry 63 12 2002 1183 1184
61. M.D. Warner, M.R. Dorn, and C.A. Peabody Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares Pharmacopsychiatry 34 4 2001 128 131
62. S.M. Southwick, J.H. Krystal, and C.A. Morgan Abnormal noradrenergic function in posttraumatic stress disorder Arch Gen Psychiatry 50 4 1993 266 274
63. N. Danchin, P. Genton, and P. Atlas Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study Int J Clin Pharmacol Ther 33 1 1995 52 55
64. M.A. Raskind, E.R. Peskind, and E.D. Kanter Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study Am J Psychiatry 160 2 2003 371 373
65. D.J. Stein, J.C. Ipser, and S. Seedat Pharmacotherapy for post traumatic stress disorder (PTSD) Cochrane Database Syst Rev 1 2006 CD002795